Literature DB >> 23325077

Nephrologist follow-up improves all-cause mortality of severe acute kidney injury survivors.

Ziv Harel1, Ron Wald, Joanne M Bargman, Muhammad Mamdani, Edward Etchells, Amit X Garg, Joel G Ray, Jin Luo, Ping Li, Robert R Quinn, Alan Forster, Jeff Perl, Chaim M Bell.   

Abstract

Survivors of severe acute kidney injury remain at high risk of death well after apparent recovery from the initial insult. Here we determine whether early nephrology follow-up after a hospitalization complicated by severe acute kidney injury associates with patient survival. This consisted of a cohort study of all hospitalized adults in Ontario from 1996 to 2008 with acute kidney injury who received temporary inpatient dialysis and survived for 90 days following discharge independent from dialysis. Propensity scores were used to match individuals with early nephrology follow-up, defined as a visit with a nephrologist within 90 days of discharge, to those without. The outcome was time to all-cause mortality of 3877 patients who met the eligibility criteria within a maximum follow-up of 2 years. A total of 1583 patients had early nephrology follow-up of whom 1184 were successfully matched 1:1 to those not receiving early follow-up. The incidence of all-cause mortality was lower in those patients with early nephrology follow-up compared with those without (8.4 compared with 10.6 per 100-patient years, hazard ratio 0.76 (95% CI: 0.62-0.93)). Thus, early nephrology follow-up after hospitalization with acute kidney injury and temporary dialysis was associated with improved survival. This finding requires definitive testing in a randomized controlled trial.

Entities:  

Mesh:

Year:  2013        PMID: 23325077     DOI: 10.1038/ki.2012.451

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  88 in total

1.  Defining renal recovery: pitfalls to be avoided.

Authors:  Frédérique Schortgen
Journal:  Intensive Care Med       Date:  2015-09-11       Impact factor: 17.440

Review 2.  Acute Renal Failure of Nosocomial Origin.

Authors:  Mark Dominik Alscher; Christiane Erley; Martin K Kuhlmann
Journal:  Dtsch Arztebl Int       Date:  2019-03-01       Impact factor: 5.594

3.  Development of a Multicenter Ward-Based AKI Prediction Model.

Authors:  Jay L Koyner; Richa Adhikari; Dana P Edelson; Matthew M Churpek
Journal:  Clin J Am Soc Nephrol       Date:  2016-09-15       Impact factor: 8.237

4.  Recovery from AKI in the critically ill: potential confounders in the evaluation.

Authors:  M Schetz; J Gunst; G De Vlieger; G Van den Berghe
Journal:  Intensive Care Med       Date:  2015-07-09       Impact factor: 17.440

5.  A nephrologist should be consulted in all cases of acute kidney injury in the ICU: We are not sure.

Authors:  Miet Schetz; Matthieu Legrand
Journal:  Intensive Care Med       Date:  2017-05-22       Impact factor: 17.440

6.  A nephrologist should be consulted in all cases of acute kidney injury in the ICU: yes.

Authors:  Hans Flaatten; Michael Darmon
Journal:  Intensive Care Med       Date:  2017-05-22       Impact factor: 17.440

Review 7.  [What rheumatologists can learn from nephrologists].

Authors:  V Schwenger
Journal:  Z Rheumatol       Date:  2018-08       Impact factor: 1.372

8.  The impact of using estimated GFR versus creatinine clearance on the evaluation of recovery from acute kidney injury in the ICU.

Authors:  M Schetz; J Gunst; G Van den Berghe
Journal:  Intensive Care Med       Date:  2014-09-30       Impact factor: 17.440

9.  Characteristics and Outcomes of Patients Discharged Home from an Emergency Department with AKI.

Authors:  Rey R Acedillo; Ron Wald; Eric McArthur; Danielle Marie Nash; Samuel A Silver; Matthew T James; Michael J Schull; Edward D Siew; Michael E Matheny; Andrew A House; Amit X Garg
Journal:  Clin J Am Soc Nephrol       Date:  2017-07-20       Impact factor: 8.237

Review 10.  Epidemiology, outcomes, and management of acute kidney injury in the vascular surgery patient.

Authors:  Charles Hobson; Nicholas Lysak; Matthew Huber; Salvatore Scali; Azra Bihorac
Journal:  J Vasc Surg       Date:  2018-06-28       Impact factor: 4.268

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.